{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:41Z","timestamp":1788142901830,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.dld.2010.07.004","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T08:18:11Z","timestamp":1282810691000},"page":"110-115","source":"Crossref","is-referenced-by-count":31,"title":["Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis"],"prefix":"10.1016","volume":"43","author":[{"given":"Dirk P.","family":"van Asseldonk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindia","family":"Jharap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Kuik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanne K.H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barend D.","family":"Westerveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice G.V.M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.G.M.","family":"Kubben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad A.","family":"van Bodegraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2010.07.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/ibd.21221","article-title":"Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts","author":"Jharap","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.07.004_bib0010","first-page":"CD006618","article-title":"Methotrexate for induction of remission in ulcerative colitis","author":"Chande","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2010.07.004_bib0015","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2010.07.004_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00054725-200108000-00001","article-title":"An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy","volume":"7","author":"Dubinsky","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.07.004_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042737-200301000-00011","article-title":"6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment","volume":"15","author":"Derijks","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.07.004_bib0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.07.004_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"Seiderer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.07.004_bib0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2007.10.013","article-title":"Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients","volume":"40","author":"De Boer","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2010.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ibd.20492","article-title":"Further experience with the use of 6-thioguanine in patients with Crohn's disease","volume":"14","author":"Ansari","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.07.004_bib0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2010.07.004_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample","volume":"583","author":"Lennard","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1016\/j.dld.2010.07.004_bib0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1373\/49.2.260","article-title":"Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods","volume":"49","author":"Shipkova","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2010.07.004_bib0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000091662","article-title":"6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party","volume":"73","author":"De Boer","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2010.07.004_bib0070","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/00365520510023369","article-title":"A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis","volume":"40","author":"Teml","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.07.004_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00365520600825166","article-title":"Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease","volume":"42","author":"Qasim","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.07.004_bib0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2008.07.314","article-title":"6-Thioguanine therapy in Crohn's disease \u2013 observational data in Swedish patients","volume":"41","author":"Almer","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2010.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","article-title":"Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine","volume":"98","author":"Dubinsky","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.07.004_bib0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2036.2003.01683.x","article-title":"Thioguanine in patients with Crohn's disease intolerant or resistant to azathioprine\/mercaptopurine","volume":"18","author":"Bonaz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.07.004_bib0095","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2125.1995.tb04478.x","article-title":"Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine","volume":"39","author":"Szumlanski","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dld.2010.07.004_bib0100","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2007.01511.x","article-title":"Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism","volume":"102","author":"De Boer","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.07.004_bib0105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.07.004_bib0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2008.10.030","article-title":"Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests","volume":"50","author":"Minervini","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.07.004_bib0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/00365520701800266","article-title":"Histopathology of liver biopsies from a thiopurine-naive inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia","volume":"43","author":"De Boer","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.07.004_bib0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.dld.2006.10.007","article-title":"Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?","volume":"39","author":"Gilissen","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2010.07.004_bib0125","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/lt.20554","article-title":"Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity","volume":"11","author":"De Boer","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2010.07.004_bib0130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00042737-200605000-00018","article-title":"Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy","volume":"18","author":"Seiderer","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.07.004_bib0135","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-Thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"Ferlitsch","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.07.004_bib0140","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00330-006-0544-3","article-title":"Thioguanine-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques","volume":"17","author":"Zech","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.dld.2010.07.004_bib0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2036.2003.01440.x","article-title":"6-Thioguanine \u2013 efficacy and safety in chronic active Crohn's disease","volume":"17","author":"Herrlinger","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865810002550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865810002550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T23:02:10Z","timestamp":1591830130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865810002550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1590865810002550"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2010.07.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}